Qube Research & Technologies LTD Harvard Bioscience Inc Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$4.02 - $5.39 $32 - $43	-8 Reduced 12.5%	56 $0
Q4 2023 Feb 13, 2024	SELL	$4.0 - $5.49 $52,076 - $71,474	-13,019 Reduced 99.51%	64 $0
Q3 2023 Nov 13, 2023	BUY	$4.0 - $5.82 $52,332 - $76,143	13,083 New	13,083 $56,000
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $6,044 - $10,168	-2,594 Reduced 7.71%	31,068 $80,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $110,411 - $216,110	33,662 New	33,662 $121,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.